{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:22:37Z","timestamp":1787178157610,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Investigate the safety and efficacy of preoperative levosimendan in patients undergoing left ventricular assist device (LVAD) implantation.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Consecutive patients who received LVADs (HeartMate-2, 3, HVAD) in a single tertiary medical center (2012\u20132018). INTERMACS profile 1 patients were excluded. The primary outcome was post-LVAD right ventricular failure (RVF) and inhospital mortality rates. The secondary outcomes included other clinical, echocardiographic and hemodynamic parameters at follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Final cohort consisted of 62 patients (40[65%] in the levosimendan group and 22[35%] in the no-levosimendan group). Post-operative RVF rate and inotrope or ventilation support time were similar in the levosimendan and no-levosimendan groups (7.5% vs. 13.6%; <jats:italic>P<\/jats:italic>\u2009=\u20090.43, median of 51 vs. 72\u00a0h; <jats:italic>P<\/jats:italic>\u2009=\u20090.41 and 24 vs. 27\u00a0h; <jats:italic>P<\/jats:italic>\u2009=\u20090.19, respectively). Length of hospitalization, both total and in the intensive care unit, was not statistically significant (median days of 13 vs. 16; <jats:italic>P<\/jats:italic>\u2009=\u20090.34, and 3 vs. 4; <jats:italic>P<\/jats:italic>\u2009=\u20090.44, respectively). Post-operative laboratory and echocardiographic parameters and in-hospital complication rate did not differ between the groups, despite worse baseline clinical parameters in the Levosimendan group. There was no significant difference in the in-hospital and long term mortality rate (2.5% vs. 4.5%; <jats:italic>P<\/jats:italic>\u2009&gt;\u20090.999 and 10% vs. 27.3% respectively; <jats:italic>P<\/jats:italic>\u2009=\u20090.64).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Levosimendan infusion prior to LVAD implantation was safe and associated with comparable results without significant improved post-operative outcomes, including RVF.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-022-01915-6","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T19:35:53Z","timestamp":1655408153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of levosimendan infusion prior to left ventricular assist device implantation on right ventricular failure"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6653-7543","authenticated-orcid":false,"given":"Amitai","family":"Segev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Lavee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigal","family":"Kassif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yedida","family":"Shemesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dov","family":"Freimark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dor","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Itelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avishay","family":"Grupper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"issue":"9","key":"1915_CR1","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.healun.2015.06.015","volume":"34","author":"BC Lampert","year":"2015","unstructured":"Lampert BC, Teuteberg JJ. Right ventricular failure after left ventricular assist devices. J Hear Lung Transplant. 2015;34(9):1123\u201330.","journal-title":"J Hear Lung Transplant"},{"issue":"1","key":"1915_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF01656260","volume":"9","author":"DJ Farrar","year":"1985","unstructured":"Farrar DJ, Compton PG, Hershon JJ, Fonger JD, Hill JD. Right heart interaction with the mechanically assisted left heart. World J Surg. 1985;9(1):89\u2013102.","journal-title":"World J Surg"},{"issue":"3","key":"1915_CR3","first-page":"163","volume":"6","author":"DJ Farrar","year":"1994","unstructured":"Farrar DJ. Ventricular interactions during mechanical circulatory support. Semin Thorac Cardiovasc Surg. 1994;6(3):163\u20138.","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"1","key":"1915_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ejcts.2011.05.047","volume":"41","author":"K Krishan","year":"2012","unstructured":"Krishan K, Nair A, Pinney S, Adams DH, Anyanwu AC. Liberal use of tricuspid-valve annuloplasty during left-ventricular assist device implantation. Eur J Cardio-thorac Surg. 2012;41(1):213\u20137.","journal-title":"Eur J Cardio-thorac Surg"},{"issue":"4","key":"1915_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/jocs.12336","volume":"29","author":"MA Brisco","year":"2014","unstructured":"Brisco MA, Sundareswaran KS, Milano CA, Feldman D, Testani JM, Ewald GA, Slaughter MS, Farrar DJ, Goldberg LR. The incidence, risk, and consequences of atrial arrhythmias in patients with continuous-flow left ventricular assist devices. J Card Surg. 2014;29(4):572\u201380.","journal-title":"J Card Surg"},{"key":"1915_CR6","first-page":"423","volume":"108","author":"F Haddad","year":"2009","unstructured":"Haddad F, Couture P, Tousignant C, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: Ii. Pathophysiology, clinical importance, and management. Anesth Analg. 2009;108:423\u201333.","journal-title":"Anesth Analg"},{"issue":"6","key":"1915_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/MAT.0000000000001088","volume":"66","author":"HJR Ali","year":"2020","unstructured":"Ali HJR, Kiernan MS, Choudhary G, Levine DJ, Sodha NR, Ehsan A, Yousefzai R. Right ventricular failure post-implantation of left ventricular assist device: prevalence, pathophysiology, and predictors. ASAIO J. 2020;66(6):610\u20139.","journal-title":"ASAIO J"},{"key":"1915_CR8","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/ejhf.733","volume":"19","author":"D Bellavia","year":"2017","unstructured":"Bellavia D, Iacovoni A, Scardulla C, Moja L, Pilato M, Kushwaha SS, Senni M, Clemenza F, Agnese V, Falletta C, Romano G, Maalouf J, Dandel M. Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies. Eur J Heart Fail. 2017;19:926\u201346.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"1915_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ccl.2020.01.007","volume":"38","author":"R Cogswell","year":"2020","unstructured":"Cogswell R, John R, Shaffer A. Right ventricular failure after left ventricular assist device. Cardiol Clin. 2020;38(2):219\u201325.","journal-title":"Cardiol Clin"},{"issue":"17","key":"1915_CR10","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1056\/NEJMoa1900486","volume":"380","author":"MR Mehra","year":"2019","unstructured":"Mehra MR, Uriel N, Naka Y, Cleveland JC, Yuzefpolskaya M, Salerno CT, Walsh MN, Milano CA, Patel CB, Hutchins SW, Ransom J, Ewald GA, Itoh A, Raval NY, Silvestry SC, Cogswell R, John R, Bhimaraj A, Bruckner BA, Lowes BD, Um JY, Jeevanandam V, Sayer G, Mangi AA, Molina EJ, Sheikh F, Aaronson K, Pagani FD, Cotts WG, Tatooles AJ, Babu A, Chomsky D, Katz JN, Tessmann PB, Dean D, Krishnamoorthy A, Chuang J, Topuria I, Sood P, Goldstein DJ. A fully magnetically levitated left ventricular assist device\u2014final report. N Engl J Med. 2019;380(17):1618\u201327.","journal-title":"N Engl J Med"},{"issue":"3","key":"1915_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jcmg.2010.10.012","volume":"4","author":"Y Topilsky","year":"2011","unstructured":"Topilsky Y, Oh JK, Shah DK, Boilson BA, Schirger JA, Kushwaha SS, Pereira NL, Park SJ. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation. JACC Cardiovasc Imaging. 2011;4(3):211\u201322.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"1915_CR12","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.healun.2017.07.005","volume":"36","author":"JK Kirklin","year":"2017","unstructured":"Kirklin JK, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Myers SL, Miller MA, Baldwin JT, Young JB, Naftel DC. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Hear Lung Transplant. 2017;36(10):1080\u20136.","journal-title":"J Hear Lung Transplant"},{"issue":"6","key":"1915_CR13","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/j.athoracsur.2015.01.036","volume":"99","author":"JM Stulak","year":"2015","unstructured":"Stulak JM, Mehta V, Schirger JA, Aaronson KD, Joyce LD, Daly RC, Pagani FD, Maltais S. Temporal differences in causes of mortality after left ventricular assist device implantation. Ann Thorac Surg. 2015;99(6):1969\u201374.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"1915_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/0091270002042001005","volume":"42","author":"M Kivikko","year":"2002","unstructured":"Kivikko M, Antila S, Eha J, Lehtonen L, Pentik\u00e4inen PJ. Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure. J Clin Pharmacol. 2002;42(1):43\u201351.","journal-title":"J Clin Pharmacol"},{"key":"1915_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.lfs.2017.07.001","volume":"184","author":"J Qiu","year":"2017","unstructured":"Qiu J, Jia L, Hao Y, Huang S, Ma Y, Li X, Wang M, Mao Y. Efficacy and safety of levosimendan in patients with acute right heart failure: a meta-analysis. Life Sci. 2017;184:30\u20136.","journal-title":"Life Sci"},{"issue":"21","key":"1915_CR16","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1056\/NEJMoa1616218","volume":"376","author":"RH Mehta","year":"2017","unstructured":"Mehta RH, Leimberger JD, Van Diepen S, Meza J, Wang A, Jankowich R, Harrison RW, Hay D, Fremes S, Duncan A, Soltesz EG, Luber J, Park S, Argenziano M, Murphy E, Marcel R, Kalavrouziotis D, Nagpal D, Bozinovski J, Toller W, Heringlake M, Goodman SG, Levy JH, Harrington RA, Anstrom KJ, Alexander JH. Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med. 2017;376(21):2032\u201342.","journal-title":"N Engl J Med"},{"issue":"21","key":"1915_CR17","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1056\/NEJMoa1616325","volume":"376","author":"G Landoni","year":"2017","unstructured":"Landoni G, Lomivorotov VV, Alvaro G, Lobreglio R, Pisano A, Guarracino F, Calabr\u00f2 MG, Grigoryev EV, Likhvantsev VV, Salgado-Filho MF, Bianchi A, Pasyuga VV, Baiocchi M, Pappalardo F, Monaco F, Boboshko VA, Abubakirov MN, Amantea B, Lembo R, Brazzi L, Verniero L, Bertini P, Scandroglio AM, Bove T, Belletti A, Michienzi MG, Shukevich DL, Zabelina TS, Bellomo R, Zangrillo A. Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med. 2017;376(21):2021\u201331.","journal-title":"N Engl J Med"},{"key":"1915_CR18","unstructured":"Interagency Registry for Mechanically Assisted Circulatory Support Manual of Operations and Procedures. 2014."},{"key":"1915_CR19","unstructured":"Performance Measure Descriptions|STS [Internet]. Cited 26 Jan 2020. https:\/\/www.sts.org\/quality-safety\/performance-measures\/descriptions#CABGCompositeScore."},{"issue":"9","key":"1915_CR20","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/0022-2828(95)90009-8","volume":"27","author":"H Haikala","year":"1995","unstructured":"Haikala H. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol. 1995;27(9):1859\u201366.","journal-title":"J Mol Cell Cardiol"},{"issue":"16","key":"1915_CR21","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/eurheartj\/ehi875","volume":"27","author":"L De Luca","year":"2006","unstructured":"De Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M. Evidence-based use of levosimendan in different clinical settings. Eur Heart J. 2006;27(16):1908\u201320.","journal-title":"Eur Heart J"},{"issue":"18","key":"1915_CR22","first-page":"2222","volume":"102","author":"MT Slawsky","year":"2000","unstructured":"Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Hutchins S, Leier CV, LeJemtel TH, Loh E, Nicklas J, Ogilby D, Singh BN, Smith W. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investig Circ. 2000;102(18):2222\u20137.","journal-title":"Study Investig Circ"},{"issue":"18","key":"1915_CR23","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1053\/euhj.2001.3158","volume":"23","author":"VS Moiseyev","year":"2002","unstructured":"Moiseyev VS, P\u00f5der P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB, Kobalava ZD, Lehtonen LA, Laine T, Nieminen MS, Lie KI, RUSSLAN Study Investigators. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: a randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J. 2002;23(18):1422\u201332.","journal-title":"Eur Heart J"},{"issue":"9328","key":"1915_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","volume":"360","author":"F Follath","year":"2002","unstructured":"Follath F, Cleland JGF, Just H, Papp JGY, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell E-P, Lehtonen L, Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet (London, England). 2002;360(9328):196\u2013202.","journal-title":"Lancet (London, England)."},{"key":"1915_CR25","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.15420\/cfr.2020.03","volume":"6","author":"Z Papp","year":"2020","unstructured":"Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, \u010cern\u00fd V, Comin-Colet J, Pollesello P, et al. Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use. Card Fail Rev. 2020;6:e19.","journal-title":"Card Fail Rev"},{"issue":"05","key":"1915_CR26","first-page":"401","volume":"68","author":"C Weber","year":"2019","unstructured":"Weber C, Esser M, Eghbalzadeh K, Sabashnikov A, Djordjevic I, Maier J, Merkle J, Choi YH, Madershahian N, Liakopoulos O, Deppe AC, Wahlers TCW. Levosimendan reduces mortality and low cardiac output syndrome in cardiac surgery. Thorac Cardiovasc Surg. 2019;68(05):401\u20139.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"1","key":"1915_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/MAT.0b013e318239f401","volume":"58","author":"S Sponga","year":"2012","unstructured":"Sponga S, Ivanitskaia E, Potapov E, Krabatsch T, Hetzer R, Lehmkuhl H. Preoperative treatment with levosimendan in candidates for mechanical circulatory support. ASAIO J. 2012;58(1):6\u201311.","journal-title":"ASAIO J"},{"issue":"3","key":"1915_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/aor.12150","volume":"38","author":"HD Theiss","year":"2014","unstructured":"Theiss HD, Grabmaier U, Kreissl N, Hagl C, Steinbeck G, Sodian R, Franz W-M, Kaczmarek I. Preconditioning with levosimendan before implantation of left ventricular assist devices. Artif Organs. 2014;38(3):231\u20134.","journal-title":"Artif Organs"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01915-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-022-01915-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01915-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T19:36:42Z","timestamp":1655408202000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-022-01915-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1915"],"URL":"https:\/\/doi.org\/10.1186\/s13019-022-01915-6","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]},"assertion":[{"value":"3 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Ethics Committee (4955-18-SMC). Consent of patients has been waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}